It is with great enthusiasm that I announce that a partnership has been formed with DLE- Medicina Laboratorial in Brazil to launch the first TMAU Urine Test in Latin America with MEBO Research on January 6, 2014. DLE has offices in two cities in Brazil, where anyone interested in doing the test can purchase their kit in person. Below is a program Introductory Letter from the DLE Administration addressed to our community. Please refer to the DLE website for additional information.
Patient information will not be disclosed by DLE to MEBO with the shipment of urine samples. Each patient’s samples will have a kit number that MEBO will use to give the test results on a spreadsheet to DLE. In turn, DLE will deliver the results to each patient according to their standard procedures.
Initially, the TMAU Urine Test provided by DLE will be available to the Brazilian public effective January 6, 2014, and eventually, we hope it will be extended to other countries as well. We extend our most deeply felt gratitude to the DLE administration for providing this service to our community.
INTRODUCTORY LETTER FROM DLE ADMINISTRATION:
"Since 1986, DLE-Medicina Laboratorial has been processing specialized tests with new technologies and new analytical methods. Many of these tests are related to rare diseases with affected individuals encountering many obstacles, frequently for many years, before arriving at a diagnosis, as is the case for persons with Trimethylaminuria (TMAU).
In February 2013, DLE incorporated the FMO3 gene sequencing test, reducing its cost by 40%, which allows more patients to have access to genetic diagnosis.
In an ongoing effort to promote accessibility to persons with rare diseases, DLE has partnered with MEBO Research to provide the Trimethylaminuria urine test for potential research throughout the Brazilian territory. The test will become available on January 06, 2014.
This test allows for a diagnosis of both Primary Trimethylaminuria (TMAU1), Trimethylaminuria linked to FMO3 gene, and Secondary Trimethylaminuria (TMAU2), which is secondary to other medical conditions. This test can also be used to monitor the progress of treatment.
This diagnostic test examines the excretion levels in urine of trimethylamine (TMA), which is responsible for the odor, and of trimethylamine N-Oxide (TMAO) 12 hours after a choline load (choline tablets provided in the sample collection kit).
How do I prepare for the test?
The day before urine collection, the patient should avoid eating foods that may interfere with the test. In addition, it is important to rule out a urinary tract infection, which can alter the levels of trimethylamine.
Test results turnaround time
is approximately 60 working days, subject to change based on the need for a minimum number of samples required to complete a batch in order to be analyzed.
To arrange for the TMAU Urine Test,
simply contact a DLE branch, DLE- São Paulo or DLE - Rio de Janeiro, to pick up a sample collection kit. The cost of the test is R$800,00 to be paid in full when picking up the kit.
For customer convenience, the sample kit can be shipped to and picked up from the client’s home in all Brazilian states by our specialized logistics, at an additional flat rate of R$200,00. Before ordering the kit, one should check available shipping logistics to your home by calling 4020-8080, local calling charges apply, or email us at canaldocliente@dle.com.br.
For more information, please visit our website, dle.com.br/tmau."
RIO DE JANEIRO Av.NSde Copacabana 1018 7th / 8th floors Rio de Janeiro / RJ CEP 22060-002 Tel: (21) 3299-3000 Fax: (21) 2521-9928 | SAO PAULO dlesp@dle.com.br Mato Grosso Street, 306 Shop 7 - Morumbi São Paulo / SP CEP 01239-040 Tel: (11) 2114-6440 Fax: (11) 2114-6441 |
María

Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.org
www.meboresearch.org
www.mebo.com.br/ (em português)
MEBO's Blog (English)
El Blog de MEBO (español)

0 comments: